Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season (northern hemisphere winter).
D000998:Antiviral Agents / Q000627:therapeutic use; D024882:Drug Resistance, Viral; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control* / Q000821:virology; D015164:Vaccines, Inactivated
D000998:Antiviral Agents; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated